InsiderTrades

Form 4 for IDN Intellicheck, Inc.

Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-10 · accession 0001628280-25-030816 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-06-11 2025-06-10 IDN Lewis Bryan CEO, Pres, Dir M - OptEx $2.56 +95.7K 373.4K +34% +$244.6K
D 2025-06-11 2025-06-10 IDN Lewis Bryan CEO, Pres, Dir F - Tax $5.97 -41.1K 407.1K -9% -$245.6K
DM 2025-06-11 2025-06-10 IDN Lewis Bryan CEO, Pres, Dir M - OptEx $0.00 -95.7K 24.6K -80% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $.001 par value 2025-06-10 M A 15,607 $2.53 389,018 D — —
2 Common Common Stock, $.001 par value 2025-06-10 M A 49,875 $2.70 448,271 D — —
3 Common Common Stock, $.001 par value 2025-06-10 M A 9,378 $3.03 398,396 D — —
4 Common Common Stock, $.001 par value 2025-06-10 M A 20,809 $2.02 373,411 D — —
5 Common Common Stock, $.001 par value 2025-06-10 F D 41,145 $5.97 407,126 D — — (F2) Reflects a weighted average price per share of $5.97 (rounded to two decimal places) for transactions between $5.82 and $6.175 per share.
6 Derivative Stock Option (Right to Buy) 2025-06-10 M D 9,378 $0.00 24,672 D $3.03 · 2023-06-30 to 2029-06-30 9,378 Common Stock, $.001 par value (F3) Of the stock options granted, 40% (45,400) of the options have no premium (i.e., exercise price equals stock price at grant); 30% (34,050) of the options would have a 25% premium (i.e., exercise price equals stock price at grant plus 25%); and 30% (34,050) of the options would have a 50% premium. (F4) One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years
7 Derivative Stock Option (Right to Buy) 2025-06-10 M D 49,875 $0.00 16,625 D $2.70 · 2024-03-03 to 2030-03-03 49,875 Common Stock, $.001 par value (F5) Of these options, 50% (66,500) have no premium (i.e. exercise price equals stock price at grant); 25% (33,250) of the options have a 20% premium (i.e. exercise price equals stock price at grant plus 20%); and 25% (33,250) of the options have a 40% premium (i.e. exercise price equals stock price at grant plus 40%). (F4) One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years
8 Derivative Stock Option (Right to Buy) 2025-06-10 M D 15,607 $0.00 18,443 D $2.53 · 2023-06-30 to 2029-06-30 15,607 Common Stock, $.001 par value (F3) Of the stock options granted, 40% (45,400) of the options have no premium (i.e., exercise price equals stock price at grant); 30% (34,050) of the options would have a 25% premium (i.e., exercise price equals stock price at grant plus 25%); and 30% (34,050) of the options would have a 50% premium. (F4) One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years
9 Derivative Stock Option (Right to Buy) 2025-06-10 M D 20,809 $0.00 24,591 D $2.02 · 2023-06-30 to 2029-06-30 20,809 Common Stock, $.001 par value (F3) Of the stock options granted, 40% (45,400) of the options have no premium (i.e., exercise price equals stock price at grant); 30% (34,050) of the options would have a 25% premium (i.e., exercise price equals stock price at grant plus 25%); and 30% (34,050) of the options would have a 50% premium. (F4) One-third of this Option shall vest upon the first anniversary of the date of grant and the remaining two-thirds of this Option shall vest quarterly over the following two years